Godavari Drugs Quarterly Results for Trading Insights
GODAVARI • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹4 Cr
QMarch 2025
Godavari Drugs Quarterly Results Key Highlights
- Revenue of ₹114 Cr in March 2025 (+0.0% vs March 2025, -27.4% vs March 2024)
- Net Profit of ₹4 Cr in March 2025 (+0.0% vs March 2025, -33.3% vs March 2024)
- EBITDA of ₹13 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 10.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹5.82 in March 2025 (+0.0% vs March 2025)
Godavari Drugs Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 106 | 114 | 157 | 160 | 161 | -7.0% | - |
| Net Profit (₹ Cr) | 4 | 4 | 6 | 4 | 5 | - | - |
| EBITDA (₹ Cr) | 11 | 13 | 14 | 11 | 12 | - | - |
| EPS (₹) | 4.90 | 5.82 | 7.37 | 5.03 | 6.97 | - | - |
| Operating Margin (%) | 10.0% | 10.0% | 8.0% | 6.0% | 7.0% | - | - |
Godavari Drugs Share Price Trend Around Quarterly Results
Visualize Godavari Drugs's 1-year price movement across quarterly results — ideal for logging trades in Godavari Drugs share price
chart using Tickjournal. All values in ₹.
Related Pages for Godavari Drugs
Additional stock information and data for GODAVARI
Revenue Trend (₹ Cr)
March 2023
160
March 2024
157
March 2025
114
2026
106
Net Profit Trend (₹ Cr)
March 2023
4
March 2024
6
March 2025
4
2026
4
Operating Margin Trend (%)
March 2023
6.0%
March 2024
8.0%
March 2025
10.0%
2026
10.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Godavari Drugs quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1782.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 137.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4092.2 | 3,219 | 591 | +11.3% | - | 18.4% | 233.3 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1467.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1242.8 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores